2021
DOI: 10.1080/08037051.2021.1922267
|View full text |Cite
|
Sign up to set email alerts
|

Continuous positive airway pressure adherence and blood pressure lowering in patients with obstructive sleep apnoea syndrome and nocturnal hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…93 The antihypertensive efficacy of CPAP is related to treatment adherence, patients who adhere to CPAP treatment for more than 5 days per week or more than 4 h per night can reduce home systolic/diastolic BP by 5.0/3.8 mm Hg more than nonadherent patients. 94 With the development of RDN devices and improvement of operator skills, recent studies have shown that RDN has short-term and long-term antihypertensive effects, and the capacity to reduce daytime and nighttime BP is comparable. [95][96][97] Compared with sham procedure, RDN with the third-generation multielectrode radiofrequency catheter in the SPYRAL HTN-ON MED trial can reduce daytime and nighttime systolic/diastolic BP in patients with uncontrolled hypertension by 6.1/4.1 and 10.0/5.1 mm Hg at 6 months, respectively.…”
Section: Device-based Treatment and Interventional Therapymentioning
confidence: 99%
See 2 more Smart Citations
“…93 The antihypertensive efficacy of CPAP is related to treatment adherence, patients who adhere to CPAP treatment for more than 5 days per week or more than 4 h per night can reduce home systolic/diastolic BP by 5.0/3.8 mm Hg more than nonadherent patients. 94 With the development of RDN devices and improvement of operator skills, recent studies have shown that RDN has short-term and long-term antihypertensive effects, and the capacity to reduce daytime and nighttime BP is comparable. [95][96][97] Compared with sham procedure, RDN with the third-generation multielectrode radiofrequency catheter in the SPYRAL HTN-ON MED trial can reduce daytime and nighttime systolic/diastolic BP in patients with uncontrolled hypertension by 6.1/4.1 and 10.0/5.1 mm Hg at 6 months, respectively.…”
Section: Device-based Treatment and Interventional Therapymentioning
confidence: 99%
“…A meta‐analysis of 10 RCTs showed that CPAP can effectively improve the 24‐h BP control in patients with OSAS and resistant hypertension, the mean systolic/diastolic BP drop during daytime and nighttime can be 2.34/2.14 and 4.15/1.95 mm Hg, respectively 93 . The antihypertensive efficacy of CPAP is related to treatment adherence, patients who adhere to CPAP treatment for more than 5 days per week or more than 4 h per night can reduce home systolic/diastolic BP by 5.0/3.8 mm Hg more than nonadherent patients 94 …”
Section: Treatmentmentioning
confidence: 99%
See 1 more Smart Citation
“…Note that there were only two randomized controlled trials included and the p value was also significant. For patients with hypertension and OSA, blood pressure was significantly reduced in those with good CPAP compliance in both patients with hypertension and resistant hypertension ( 38 , 39 ). Systolic and diastolic blood pressure were lower by 3.9 and 3.5 mmHg, respectively in patients with resistant hypertension.…”
Section: Osa and Cardiovascular Consequences: A Clinical Reviewmentioning
confidence: 99%